SNCA antibody - middle region
Product name: | SNCA antibody - middle region |
Source: | Rabbit |
Purity: | >95% |
Buffer Formulation: | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Note: The product is for research use only,not for use in diagnostic or therapeutic procedures. Catalog Number:OM105240 Price:$325.00 Discount Price Size: Store:In stock |
Applications: | WB |
Storage: | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
UOM: | 100ug |
Rabbit anti-SNCA polyclonal antibody - middle region
Catalog Number:IC110856
- 1
- 2
Product Profile
ProductName | Rabbit anti-SNCA polyclonal antibody - middle region |
---|---|
AntibodyType | Primary Antibodies |
Immunogen |
The immunogen for anti-SNCA antibody: synthetic peptide directed towards the middle region of human SNCA |
Key Feature
Clonality | Polyclonal |
---|---|
Isotype | IgG |
Host Species | Rabbit |
Tested Applications | |
Species Reactivity | |
Concentration | 1mg/ml |
Purification | Affinity purified |
Target Information
Gene Symbol | SNCA |
---|---|
Gene Synonyms |
MGC110988
More
NACP PARK1 PARK4 PD1 |
Gene Full Name | Synuclein, alpha (non A4 component of amyloid precursor) |
Gene Summary |
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease.Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Two alternatively spliced transcripts of SNCA have been identified. Additional splicing may be present but the full-length nature of these variants has not been determined.
More
|
Alternative Names |
MGC110988
More
NACP PARK1 PARK4 PD1 |
MolecularWeight(MW) | 11kDa |
Sequence | 112 amino acids |
Database Links
Entrez Gene | 6622 |
---|---|
SwissProt ID | P37840-2 |
Protein Accession | NP_009292 |
Application
-
Western blot
Host: Rabbit
Target Name: NSUN6
Sample Tissue: Human Fetal Lung
Antibody Dilution: 1.0ug/ml -
Western blot
Host: Rabbit
Target Name: FAM46C
Sample Tissue: Human Fetal Liver
Antibody Dilution: 1.0ug/ml -
Western blot
0.2-1 ug/ml
ELISA Titer: 1:62500
Positive Control: HepG2 cell lysate
Additional Information
Form | Liquid |
---|---|
Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.